BiotechTube
Home/Excision BioTherapeutics/Andrew Schiermeier, Ph.D.
AS

Andrew Schiermeier, Ph.D.

Chief Operating Officer

Excision BioTherapeutics

Roles

Chief Operating OfficeratExcision BioTherapeutics
Chief Executive OfficeratAvenCell Therapeutics

Therapeutic Areas

Infectious DiseaseGenetic Disorders

Excision BioTherapeutics Pipeline

DrugIndicationPhase
EBT-101HIV-1 InfectionPhase 1/2
Preclinical ProgramHerpes Simplex Virus (HSV) InfectionPreclinical

Leadership Team at Excision BioTherapeutics

DD
Daniel Dornbusch
Chief Executive Officer
LD
Lisa Danzig, M.D.
Chief Medical Officer
KK
Kamel Khalili, Ph.D.
Co-Founder & Scientific Advisor
View full Excision BioTherapeutics profile